These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3059767

  • 1. Identification and characterization of a non-interferon antileishmanial macrophage activating factor (antileishmanial MAF).
    Van Niel A, Zacks SE, David JR, Remold HG, Weiser WY.
    Adv Exp Med Biol; 1988; 239():231-7. PubMed ID: 3059767
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE, Grabstein KH, Okuno K, Schreiber RD, Greenberg PD.
    J Immunol; 1989 Dec 15; 143(12):4308-16. PubMed ID: 2687379
    [Abstract] [Full Text] [Related]

  • 4. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
    Lee JC, Rebar L, Young P, Ruscetti FW, Hanna N, Poste G.
    J Immunol; 1986 Feb 15; 136(4):1322-8. PubMed ID: 3003193
    [Abstract] [Full Text] [Related]

  • 5. T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.
    Sypek JP, Wyler DJ.
    Infect Immun; 1990 May 15; 58(5):1146-52. PubMed ID: 2323812
    [Abstract] [Full Text] [Related]

  • 6. Partial purification and characterization of a human lymphokine which induces antileishmanial activity in mouse macrophages.
    Buchmuller Y, Weiser WY, Remold HG.
    Cell Immunol; 1985 Jan 15; 90(1):242-50. PubMed ID: 3881189
    [Abstract] [Full Text] [Related]

  • 7. A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.
    Hoover DL, Finbloom DS, Crawford RM, Nacy CA, Gilbreath M, Meltzer MS.
    J Immunol; 1986 Feb 15; 136(4):1329-33. PubMed ID: 3080522
    [Abstract] [Full Text] [Related]

  • 8. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
    Taniyama T, Taki S, Akiyama Y, Yoshizawa K, Hamuro J, Arai K, Wong GG.
    Clin Invest Med; 1990 Dec 15; 13(6):305-12. PubMed ID: 2127737
    [Abstract] [Full Text] [Related]

  • 9. Role of lymphokines in regulation of macrophage differentiation.
    Onozaki K, Akagawa KS, Haga S, Miura K, Hashimoto T, Tokunaga T.
    Cell Immunol; 1983 Feb 15; 76(1):129-36. PubMed ID: 6339080
    [Abstract] [Full Text] [Related]

  • 10. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR, Hoyer M, Leyko MA, Horvat R, Parmely M, Whitacre C, Zwilling B, Rinehart JJ.
    Cancer Res; 1985 May 15; 45(5):1940-5. PubMed ID: 3921233
    [Abstract] [Full Text] [Related]

  • 11. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
    Ratliff TL, Thomasson DL, McCool RE, Catalona WJ.
    J Reticuloendothel Soc; 1982 May 15; 31(5):393-7. PubMed ID: 6181257
    [Abstract] [Full Text] [Related]

  • 12. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
    Nathan CF, Murray HW, Wiebe ME, Rubin BY.
    J Exp Med; 1983 Sep 01; 158(3):670-89. PubMed ID: 6411853
    [Abstract] [Full Text] [Related]

  • 13. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
    Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlik JR, Vilcek J.
    J Immunol; 1983 Dec 01; 131(6):2821-6. PubMed ID: 6417232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
    Cameron DJ.
    J Clin Lab Immunol; 1984 Jan 01; 13(1):47-50. PubMed ID: 6371237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset.
    Nakajima H, Izumi Y, Sugihara S, Satoh Y, Isumi S, Gotoh T, Fujiwara H, Hamaoka T.
    Cancer Immunol Immunother; 1987 Jan 01; 25(3):201-8. PubMed ID: 3119213
    [Abstract] [Full Text] [Related]

  • 20. Macrophage activation for antileishmanial defense by an apparently novel mechanism.
    Wyler DJ, Beller DI, Sypek JP.
    J Immunol; 1987 Feb 15; 138(4):1246-9. PubMed ID: 3100630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.